Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Balance, beginning at Dec. 31, 2021 $ (21,450) $ 49 $ 220,022 $ (255) $ (241,266)
Balance, beginning (in shares) at Dec. 31, 2021   49,311,864      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation 5   5    
Unrealized gain on debt securities available for sale (net of tax) 350     350  
Reclassification adjustment for gain included in net income 7     7  
Foreign currency translation effect 331     331  
Net loss (1,542)       (1,542)
Balance, ending at Mar. 31, 2022 (22,299) $ 49 220,027 433 (242,808)
Balance, ending (in shares) at Mar. 31, 2022   49,311,864      
Balance, beginning at Dec. 31, 2022 (34,091) $ 50 220,815 (2,619) (252,337)
Balance, beginning (in shares) at Dec. 31, 2022   49,583,501      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Change in fair value of warrants including down-round protection adjustments     41   (41)
Convertible notes converted to shares (in shares)   1,351,351      
Convertible notes converted to shares 500 $ 1 499    
Warrants issued for services 334   334    
Share-based compensation 1,189   1,189    
Unrealized gain on debt securities available for sale (net of tax) (544)     (544)  
Foreign currency translation effect 186     186  
Net loss (3,527)       (3,527)
Balance, ending at Mar. 31, 2023 $ (35,953) $ 51 $ 222,878 $ (2,977) $ (255,905)
Balance, ending (in shares) at Mar. 31, 2023   50,934,852